Table 1.
Distribution of survey respondents according to different variables (n = 1018)
| No. (%) | |
|---|---|
| Age (years) | |
| < 20 | 38(3.7%) |
| 20–40 | 733(72%) |
| 40–60 | 235(23.1%) |
| > 60 | 12 (1.2%) |
| Gender | |
| Female | 858 (84.3%) |
| Male | 160 (15.7%) |
| Occupation | |
| Full-time job | 526 (51.7%) |
| I don’t work | 208 (20.4%) |
| Student | 116 (11.4%) |
| Part-time job | 107 (10.5%) |
| Retired | 61 (6%) |
| Marital status | |
| Married | 629 (61.8%) |
| Single | 324 (31.8%) |
| Divorced | 55 (5.4%) |
| Widow | 4 (0.4%) |
| Other | 6 (0.6%) |
| Education | |
| High school | 456 (44.8%) |
| Primary school or less | 282 (27.7%) |
| University | 280 (27.5%) |
| Disease onset (years) | |
| Mean ± SD. | 9.8 ± 8.3 |
| Median (Min. – Max.) | 7 (1–46) |
| Increase in Migraine severity | 653 (64.1%) |
| Increase in Migraine frequency | 607 (59.6%) |
| Degree of severity increase | |
| Did not increase | 365 (35.9%) |
| Moderate increase | 357 (35.1%) |
| Significant increase | 231 (22.7%) |
| Slight increase | 65 (6.4%) |
| Migraine days (before pandemic) | |
| Mean ± SD. | 5.7 ± 5.5 |
| Median (Min. – Max.) | 4 (0–30) |
| Migraine days (during pandemic) | |
| Mean ± SD. | 8 ± 7.1 |
| Median (Min. – Max.) | 5 (0–30) |
| Decrease in migraine days | 163 (16%) |
| Medication overuse | 597 (58.7%) |
| Compliance to migraine treatment | 477 (46.9%) |
| Difficulty in getting medications | 256 (25.1%) |
| Emergency department visit | 228 (22.4%) |
| Chronification of migraine during pandemic | 105 (10.3%) |
| Communication with treating physician | |
| Did not contact for the duration of the pandemic | 626 (61.5%) |
| Visiting the doctor / hospital | 136 (13.4%) |
| Telephone | 100 (9.8%) |
| Social media | 98 (9.6%) |
| Other | 38(3.7%) |
| Telemedicine clinics | 20 (2%) |
| Worries and concerns during pandemic | |
| Infection with COVID-19 | 571 (56.1%) |
| Increase migraine severity and/or frequency | 445 (43.7%) |
| Unavailability of medications | 174 (17.1%) |
| Social, financial and family problems | 175 (17.1%) |
| Losing their jobs | 50 (4.9%) |
| Other concerns | 136 (13.4%) |
| Sleep disturbance | 794 (78.1%) |
| Increase screen time exposure | 905 (88.9%) |
| Symptoms of anxiety and/or depression | 809 (79.5%) |
| Eating habits disturbance | 593 (58.3%) |
| Working during pandemic | 465 (45.7%) |
| Use of alternative/ traditional medicine | 406 (39.9%) |
| Lack of regular exercise | 812 (79.7%) |
| Negative effect of Botox injection cancellation | |
| No | 77 (33.9%) |
| Yes | 150 (66.1%) |
| COVID-19 infection | 41 (4%) |
| Headache worsening during COVID-19 infection | |
| No | 15 (36.6%) |
| Yes | 26 (63.4%) |